SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bal Pharma informs about trading window closure

27 Dec 2021 Evaluate
Bal Pharma has informed that the trading window for dealing with the securities of the Company on the designated employees and their relatives will be closed from 1st January 2022 and up to 48 hours of the declaration of the financial results of the Company, for the quarter ended 31/12/2021. The date of the Board meeting for 
declaration of the financial results for quarter ended 31th December 2021 will be intimated to the exchange in due course.

The above information is a part of company’s filings submitted to BSE.

Bal Pharma Share Price

78.10 0.80 (1.03%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×